Eagle Pharmaceuticals
EGRX
#9973
Rank
NZ$14.6 M
Marketcap
$1.13
Share price
-7.14%
Change (1 day)
-85.30%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: NZ$14.6 Million

As of December 2024 Eagle Pharmaceuticals has a market cap of NZ$14.6 Million. This makes Eagle Pharmaceuticals the world's 9973th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$14.6 M-86.4%
2023NZ$0.10 B-82.08%
2022NZ$0.59 B-37.76%
2021NZ$0.96 B14.47%
2020NZ$0.84 B-30.83%
2019NZ$1.21 B45.49%
2018NZ$0.83 B-25.54%
2017NZ$1.12 B-36.68%
2016NZ$1.77 B-12.5%
2015NZ$2.02 B629.53%
2014NZ$0.27 B

End of Day market cap according to different sources

On Dec 16th, 2024 the market cap of Eagle Pharmaceuticals was reported to be:

N/A
by Nasdaq info icon info icon
NZ$14.6 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$600.58 B 4,111,774.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$119.23 B 816,245.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$342.06 B 2,341,865.49%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$32.43 B 221,994.66%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
NZ$248.41 B 1,700,664.91%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.214 T 8,317,379.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$196.49 B 1,345,224.73%๐Ÿ‡บ๐Ÿ‡ธ USA